2.88
+0.32(+12.50%)
Currency In USD
| Previous Close | 2.56 |
| Open | 2.55 |
| Day High | 3.07 |
| Day Low | 2.5 |
| 52-Week High | 162.5 |
| 52-Week Low | 1.05 |
| Volume | 868,207 |
| Average Volume | 86,235 |
| Market Cap | 2.3M |
| PE | -0.06 |
| EPS | -51.81 |
| Moving Average 50 Days | 4.7 |
| Moving Average 200 Days | 15.96 |
| Change | 0.32 |
If you invested $1000 in NanoVibronix, Inc. (NAOV) 10 years ago, it would be worth $2.73 as of February 21, 2026 at a share price of $2.88. Whereas If you bought $1000 worth of NanoVibronix, Inc. (NAOV) shares 5 years ago, it would be worth $9.7 as of February 21, 2026 at a share price of $2.88.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line
GlobeNewswire Inc.
Jan 28, 2026 2:00 PM GMT
Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channelsTYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
GlobeNewswire Inc.
Jan 21, 2026 1:30 PM GMT
Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growthTYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NA
ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription
GlobeNewswire Inc.
Jan 14, 2026 1:30 PM GMT
New Product Line Enhances Continuity of Care Across Clinical and Home SettingsTYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology compan